With decades of biopharmaceutical industry experience in CGMP facility design, software, engineering, manufacturing and Quality operations, Lykan Bioscience provides the first true end-to-end solution for cell-based therapies, including shipping and logistics.
Our experienced team provides Process Development and CGMP manufacturing for autologous and allogeneic cell-based therapies in concert with our Quality Management System which serves the entire product lifecycle.
Lykan can meet your immediate needs with capacity availability and also offer long-term vision toward scalability, validation and high-throughput commercial manufacture of your cell-based therapies, whether they are CAR-T, TCR, TIL, iPSC, or other platforms.